中文摘要
本篇論文共分為四個章節，主要是利用金、銀催化劑對烯炔類等不飽和鍵的活化並與疊氮化合物或含氧化合物進行環化反應或加成還化反應。
第一章我們利用了疊氮酮類化合物I-1a與苯炔進行反應，並且在銀催化劑的輔助下可以遮蔽活性較高的一號位置並且使第二當量的苯炔加成至二號位置而得到2-吲唑(indazole)化合物I-3a。

在第二章中我們金催化劑活化2-炔苄基醚類化合物II-1a，並且加入疊氮化合物II-2a進行反應，對於此反應我們認為化合物II-1a被經催化劑活化後會先形成Oxonium的中間體II-I後再由疊氮化合物II-2a進行加成反應與Roskamp的重排反應進而得到環化產物II-3a。
第三章我們描述了2-炔基苄基醚類化合物III-3a在酸性較高的催化劑P(C6F5)3AuSbF6與硝基甲烷的反應環境下可得到1-茚酮化合物，而再P(t-Bu)2(o-biphenyl)AuNTf2與二氯乙烷的反應環境下可得到2-茚酮化合物，並且我們以同位素實驗來證明反應機構的產生。

而最後一章我們利用了金催化劑活化3-烯丁醇類化合物IV-1a，使自身進行雙聚合反應而得到多取代的四氫吡喃(Pyran)化合物IV-2a，而反應過程中並無2-oxonia-Cope rearrangement的產生而得到額外的副產物。

[1] (a) R. F. Heck, Jr., J. P. Nolley, J. Org. Chem. 1972, 37 , 2320. (b) T. Mizoroki, K. Mori, A. Ozaki, Bull. Chem. Soc. Jap. 1971, 44, 581. (c) A. F. Littke, G. C. Fu, Org. Synth. 2005, 81, 63 (d) R. F. Heck, Org. React. 1982, 27, 345. (e) A. de Meijere, Jr. F. E. Meyer, Angew. Chem. Int. Ed. 1994, 33, 2379. (f) I. P. Beletskaya, A. V. Cheprakov, Chem. Rev. 2000, 100 , 3009.
[2] (a) A. O. King, N. Okukado, E.-i. Negishi, Journal of the Chemical Society Chemical Communications, 1977, 683. (b) J. A. Casares, P. Espinet, B. Fuentes, G. Salas. J. Am. Chem. Soc. 2007, 129, 3508. (c) Q. Liu, Y. Lan, J. Liu, G. Li, Y.-D. Wu, A. Lei, J. Am. Chem. Soc.,2009, 131, 10201. (d) A. P. Smith, S. A. Savage, J. C. Love, C. L. Fraser, Org. Synth.2004, 10, 517. (e) E.-i. Negishi, T. Takahashi, A. O. King, Org. Synth.1993, 8, 430. (f) E.-i. Negishi, T. Takahashi, S. Baba, Org. Synth.1993, 8, 295.
[3] (a)N. Miyaura, K. Yamada, A. Suzuki, Tetrahedron Letters 1979, 20, 3437. (b) N. Miyaura, A. Suzuki, Chem. Comm. 1979, 866. (c) N. Miyaura, A. Suzuki, Chemical Reviews, 1995, 95, 2457. (d) A.Suzuki. Pure & Appl. Chem., 1991, 63, 419. (e) A. Suzuki, Journal of Organometallic Chemistry 1999, 576, 147.
[4] Nobelprize.org. "The Nobel Prize in Chemistry 2010". Nobel Prize Foundation. Retrieved 2013-10-25.
[5] I. J. Blackmore, A. J. Bridgeman, M. A. Harris, M. A. Holdaway, J. F. Rooms, E. L. Thompson, N. A. Young, Angew. Chem. Int. Ed. 2005, 44, 6746-6750.
[6] (a) P. Pyykkö, Angew. Chem. Int. Ed. 2003, 42, 4442. (b) V. Michelet, P. Y. Toullec, J.-P. Genêt, Angew. Chem. Int. Ed. 2008,47, 2-50.
[7] (a) J.-J. Lian, P.-C. Chen, Y.-P. Lin, Liu, R.-S. J. Am. Chem. Soc. 2006, 128, 11372. (b) L. M. Zhang, J. Am. Chem. Soc. 2005, 127, 16804. (c) D. Xing, B. Guan, G. Cai, Z. Fang, L. Yang, Z. Shi, Org. Lett. 2006, 8, 693. (d) R. Zhao, D. Ji, G. Lu, G. Qian, L. Yan, X. Wang, J. Chem. Commun. 2004, 904. (e) A. S. K. Hashmi, Angew. Chem. Int. Ed. 2005, 44, 6990. (f) S. Ma, S. Yu, Z. Gu, Angew. Chem. Int. Ed. 2006, 45, 200. (g) Y. Fukuda, K. Utimoto, H. Nozaki, Heterocycles 1987, 25, 297.
[8] (a) S. Brase, C. Gil, K. Knepper, Bioorg. Med. Chem. 2002, 10, 2415. (b) M. De Lena, V. Lorusso, A. Latorre, G. Fanizza, G. Gargano, L. Caporusso, M. Guida, A. Catino, E. Crucitta, D. Sambiasi, A. Mazzei, Eur. J. Cancer 2001, 37, 364. (c) J.-H. Sun, C. A. Teleha, J.-S. Yan, J. D. Rodgers, D. A. Nugiel, J. Org. Chem. 1997, 62, 5627. (d) J. D. Rodgers, B. L. Johnson, H. Wang, R. A. Greenberg, S. Erickson-Viitanen, R. M. Klabe, B. C. Cordova, M. M. Rayner, G. N. Lam, C.-H. Chang, Biomed. Chem. Lett. 1996, 6, 2919. (e) B. K. Keppler, M. Hartmann, Met.-Based Drugs 1994, 1, 145.
[9] (a) A. Schmidt, Adv. Heterocycl. Chem. 2003, 85, 67. (b) Atta-ur-Rahman, S. Malik, H. Cun-heng, J. Clardy, Tetrahedron Lett. 1985, 26, 2759. (c) A. Schmidt, Curr. Org. Chem. 2004, 8, 653. (d) Y.-M. Liu, J.-S. Yang, Q.-H. Liu, Chem. Pharm. Bull. 2004, 52, 454. (e) Atta-ur-Rahman, S. Malik, S. S. Hasan, M. I. Choudhary, C.-Z. Ni, J. Clardy, Tetrahedron Lett. 1995, 36, 1993.
[10] T. Yamazaki, G. Baum, H. Shechter, Tetrahedron Lett. 1974, 15, 4421.
[11] T. Jin and Y. Yamamoto, Angew. Chem., Int. Ed., 2007, 46, 3323.
[12] Z. Liu, F. Shi, P. D. G. Martinez, C. Raminelli and R. C. Larock, J. Org. Chem., 2008, 73, 219.
[13] J. J. Song, N. K. Yee, Org. Lett. 2000, 2, 519
[14] Earlier examples: (a) J. Elguero, In ComprehensiVe Heterocyclic Chemistry; A. R. Katritzky, C. W. Rees, Eds. Pergamon: New York, 1984; Vol. 5, p 167. (b) E. G. Kovach, D. E. Barnes, J. Am. Chem. Soc. 1954, 76, 1176.
[15] Select recently examples : (a) P. Li, C. Wu, J. Zhao, D. C. Rogness, F. Shi, J. Org. Chem., 2012, 77, 3149 (b) Y. Fang, C. Wu, R. C. Larock, F. Shi, J. Org. Chem. 2011, 76, 8840 (c) M. R. Kumar, A. Park, N. Park, S. Lee, Org. Lett. 2011, 13, 3542 (d) P. Li, J. Zhao, C. Wu, R. C. Larock, F. Shi Org. Lett. 2011, 13, 3340 (e) C. Li, T. Zhang, Z. Zeng, X. Liu, Y. Zhao, B. Zhang, Y. Feng Org. Lett. 2012, 14, 47 (f) C. Wu, Y. Fang, R. C. Larock, F. Shi, Org. Lett. 2010, 12, 2234.
[16] (a) R. Huisgen, R. Knorr, Naturwissenschaften 1961, 48, 716. (b) W. Reid, M. Schőn, Ann. Chem. 1965, 869, 141. (c) G. Baum, R. Bernard, H. Shechter, J. Am. Chem. Soc. 1967, 89, 5307. (d) G. Baum, H. Shechter, J. Org. Chem.1976, 41, 2120. (e) T. Yamazaki, H. Shechter, Tetrahedron Lett. 1972, 13, 4533. (f) T. Yamazaki, G. Baum, H. Shechter, Tetrahedron Lett. 1974, 15, 4421.
[17] Z. Liu, F. Shi, P. D. G. Martinez, C. Raminelli, R.C. Larock J. Org. Chem. 2008, 73, 219
[18] (a) T. Jin, Y. Yamamoto, Angew. Chem. Int. Ed. 2007, 46, 3323. (b) T. Jin, F. Yang, Y. Yamamoto, Collect. Czech. Chem. Commun., 2009, 74, 957.
[19] A. Schmidt, A. Beutler, B. Snovydovych, Eur. J. Org. Chem. 2008, 4073.